Indian pharmaceutical company Strides Arcolab has entered into a licensing agreement with US-based Gilead Sciences to manufacture and distribute latter's low-cost HIV drug, Tenofovir Alafenamide (TAF), in developing countries. In a BSE filing, Strides Arcolab said, "It has entered into a licensing agreement with Gilead Sciences, Inc under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), ...
Read More
You have just read an article categorized health
titled Strides Arcolab Inks Deal With Gilead Sciences for HIV Drug.
Written by:
editor -
Thursday, January 22, 2015
There are currently no comments for "Strides Arcolab Inks Deal With Gilead Sciences for HIV Drug"
Post a Comment